Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation

Although the herbal pair of Euphorbia kansui (GS) and Glycyrrhiza (GC) is one of the so-called "eighteen antagonistic medicaments" in Chinese medicinal literature, it is prescribed in a classic Traditional Chinese Medicine (TCM) formula Gansui-Banxia-Tang for cancerous ascites, suggesting that GS and GC may exhibit synergistic or antagonistic effects in different combination designs. Here, we modeled the effects of GS/GC combination with a target interaction network and clarified the associations between the network topologies involving the drug targets and the drug combination effects. Moreover, the "edge-betweenness" values, which is defined as the frequency with which edges are placed on the shortest paths between all pairs of modules in network, were calculated, and the ADRB1-PIK3CG interaction exhibited the greatest edge-betweenness value, suggesting its crucial role in connecting the other edges in the network. Because ADRB1 and PIK3CG were putative targets of GS and GC, respectively, and both had functional interactions with AVPR2 approved as known therapeutic target for ascites, we proposed that the ADRB1-PIK3CG-AVPR2 signal axis might be involved in the effects of the GS-GC combination on ascites. This proposal was further experimentally validated in a H22 hepatocellular carcinoma (HCC) ascites model. Collectively, this systems-level investigation integrated drug target prediction and network analysis to reveal the combination principles of the herbal pair of GS and GC. Experimental validation in an in vivo system provided convincing evidence that different combination designs of GS and GC might result in synergistic or antagonistic effects on HCC ascites that might be partially related to their regulation of the ADRB1-PIK3CG-AVPR2 signal axis.

[1]  Yanqiong Zhang,et al.  A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Wu Tou Tang Acting on Rheumatoid Arthritis by Integrating Network Analysis , 2013, Evidence-based complementary and alternative medicine : eCAM.

[2]  B. Salimath,et al.  Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. , 2006, International immunopharmacology.

[3]  Shiuan-Pey Lin,et al.  Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A. , 2012, Food chemistry.

[4]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[5]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[6]  Jinpu Yu,et al.  The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites model , 2012, Molecular and Cellular Biochemistry.

[7]  Y. Li,et al.  Development of novel 5‐fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites , 2010, Journal of gastroenterology and hepatology.

[8]  I. Sakaida.  Tolvaptan for the treatment of liver cirrhosis oedema , 2014, Expert review of gastroenterology & hepatology.

[9]  L. Graziosi,et al.  Malignant ascites: pathophysiology and treatment , 2013, International Journal of Clinical Oncology.

[10]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[11]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[12]  Aniko Simon,et al.  eHiTS: an innovative approach to the docking and scoring function problems. , 2006, Current protein & peptide science.

[13]  C. Ling,et al.  Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review. , 2012, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[14]  Xiaolin Hao,et al.  Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease. , 2015, Journal of medicinal chemistry.

[15]  M. Sherman.  Recurrence of hepatocellular carcinoma. , 2008, The New England journal of medicine.

[16]  Yanqiong Zhang,et al.  MicroRNA‐101 suppresses SOX9‐dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma , 2012, FEBS letters.

[17]  T. Boyer,et al.  Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia , 2012, Therapeutic advances in gastroenterology.

[18]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[19]  Thomas Schlitt,et al.  Protein-protein interaction databases: keeping up with growing interactomes , 2009, Human Genomics.

[20]  J. Chen,et al.  HAPPI: an online database of comprehensive human annotated and predicted protein interactions , 2009, BMC Genomics.

[21]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[22]  Chin-Lee Wu,et al.  MicroRNA‐224 inhibits progression of human prostate cancer by downregulating TRIB1 , 2014, International journal of cancer.

[23]  Yanqiong Zhang,et al.  A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma , 2014, Scientific Reports.

[24]  Yanqiong Zhang,et al.  Identification of GRB2 and GAB1 Coexpression as an Unfavorable Prognostic Factor for Hepatocellular Carcinoma by a Combination of Expression Profile and Network Analysis , 2013, PloS one.

[25]  Yanqiong Zhang,et al.  Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation. , 2014, Molecular bioSystems.

[26]  Thomas Hankemeier,et al.  Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. , 2010, Planta medica.

[27]  Xuegong Zhang,et al.  Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.

[28]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[29]  Hongjuan Lu,et al.  Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase. , 2008, Cancer letters.

[30]  Igor Jurisica,et al.  Online Predicted Human Interaction Database , 2005, Bioinform..

[31]  H. Vilstrup,et al.  Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development , 2013, Metabolic Brain Disease.

[32]  J. Tamsma.  The pathogenesis of malignant ascites. , 2007, Cancer treatment and research.

[33]  E Schäfer,et al.  [Treatment of malignant ascites]. , 2008, Deutsche medizinische Wochenschrift.

[34]  I. Makhoul,et al.  Congenital Hypothyroidism and Nonimmune Hydrops Fetalis: Associated? , 1999, Pediatrics.

[35]  F. Yu,et al.  Isolation and characterization of methyl esters and derivatives from Euphorbia kansui (Euphorbiaceae) and their inhibitory effects on the human SGC-7901 cells. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[36]  Lucy Skrabanek,et al.  PDZBase: a protein?Cprotein interaction database for PDZ-domains , 2005, Bioinform..

[37]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[38]  Na Lin,et al.  A Systems Biology-Based Approach to Uncovering the Molecular Mechanisms Underlying the Effects of Dragon's Blood Tablet in Colitis, Involving the Integration of Chemical Analysis, ADME Prediction, and Network Pharmacology , 2014, PloS one.

[39]  E. Decuypere,et al.  Myocardial beta-adrenergic receptor characteristics in T(3)-induced ascites and in broiler lines differing in ascites susceptibility. , 1997, Avian pathology : journal of the W.V.P.A.

[40]  Shao Li,et al.  Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation , 2015, Scientific Reports.

[41]  A. Ding,et al.  Processing of Kansui Roots Stir-Baked with Vinegar Reduces Kansui-Induced Hepatocyte Cytotoxicity by Decreasing the Contents of Toxic Terpenoids and Regulating the Cell Apoptosis Pathway , 2014, Molecules.

[42]  H. Narchi.  Congenital hypothyroidism and nonimmune hydrops fetalis: associated? , 1999, Pediatrics.

[43]  A. Tapia-Abellán,et al.  Role of MAP Kinases and PI3K‐Akt on the cytokine inflammatory profile of peritoneal macrophages from the ascites of cirrhotic patients , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[44]  L. Jia,et al.  Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model. , 2010, Current drug metabolism.

[45]  Guanwei Fan,et al.  Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions. , 2013, Journal of ethnopharmacology.